Should we routinely evaluate serum alkaline phosphatase levels in patients with gout?
Hyperuricemia and gout can be seen in patients with Paget's disease of bone (PD). This may be secondary to increased nucleic acid turnover in accelerated bone remodeling. It is unclear whether all PD patients should be evaluated for the presence of PD and gout in the same patient. In this report, I present a gout patient who later diagnosed as having PD and discuss the relationship between gout and PD.
Korkmaz
Cengiz
C
Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, İc Hastalıkları, Romatoloji BD, Eskisehir, Turkey. ckorkmaz@ogu.edu.tr
D019386:Alendronate / Q000627:therapeutic use; D000469:Alkaline Phosphatase / Q000097:blood*; D000493:Allopurinol / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003078:Colchicine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006073:Gout / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000150:complications / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D010349:Patient Compliance
D015415:Biomarkers; D006074:Gout Suppressants; D000493:Allopurinol; D000469:Alkaline Phosphatase; D003078:Colchicine; D019386:Alendronate